Search

Gill Worthy

Obinutuzumab in Combination with Chemotherapy for the First-Line Treatment of Patients with Advanced Follicular Lymphoma: An Evidence Review Group Evaluation of the NICE Single Technology Appraisal

Published with Wowchemy — the free, open source website builder that empowers creators.